1. Home
  2. AUPH vs LAC Comparison

AUPH vs LAC Comparison

Compare AUPH & LAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • LAC
  • Stock Information
  • Founded
  • AUPH 1993
  • LAC 2023
  • Country
  • AUPH Canada
  • LAC Canada
  • Employees
  • AUPH N/A
  • LAC N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • LAC Metal Mining
  • Sector
  • AUPH Health Care
  • LAC Basic Materials
  • Exchange
  • AUPH Nasdaq
  • LAC Nasdaq
  • Market Cap
  • AUPH 1.0B
  • LAC 856.0M
  • IPO Year
  • AUPH 1999
  • LAC N/A
  • Fundamental
  • Price
  • AUPH $8.12
  • LAC $3.73
  • Analyst Decision
  • AUPH Strong Buy
  • LAC Hold
  • Analyst Count
  • AUPH 3
  • LAC 8
  • Target Price
  • AUPH $10.33
  • LAC $5.06
  • AVG Volume (30 Days)
  • AUPH 1.3M
  • LAC 13.9M
  • Earning Date
  • AUPH 11-07-2024
  • LAC 11-07-2024
  • Dividend Yield
  • AUPH N/A
  • LAC N/A
  • EPS Growth
  • AUPH N/A
  • LAC N/A
  • EPS
  • AUPH N/A
  • LAC N/A
  • Revenue
  • AUPH $220,361,000.00
  • LAC N/A
  • Revenue This Year
  • AUPH $36.52
  • LAC N/A
  • Revenue Next Year
  • AUPH $19.02
  • LAC N/A
  • P/E Ratio
  • AUPH N/A
  • LAC N/A
  • Revenue Growth
  • AUPH 38.72
  • LAC N/A
  • 52 Week Low
  • AUPH $4.71
  • LAC $2.02
  • 52 Week High
  • AUPH $10.05
  • LAC $7.71
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 62.64
  • LAC 50.76
  • Support Level
  • AUPH $8.06
  • LAC $3.73
  • Resistance Level
  • AUPH $8.70
  • LAC $4.50
  • Average True Range (ATR)
  • AUPH 0.34
  • LAC 0.42
  • MACD
  • AUPH 0.07
  • LAC -0.07
  • Stochastic Oscillator
  • AUPH 63.74
  • LAC 7.55

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About LAC Lithium Americas Corp.

Lithium Americas is a pure-play lithium producer. The firm owns 62% of one resource, Thacker Pass, that is located in northwest Nevada, with automaker General Motors owning the remaining 38%. Thacker Pass recently began construction and is expected to begin production in the mid- to late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.

Share on Social Networks: